1. Home
  2. GPCR vs LMB Comparison

GPCR vs LMB Comparison

Compare GPCR & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • LMB
  • Stock Information
  • Founded
  • GPCR 2016
  • LMB 1901
  • Country
  • GPCR United States
  • LMB United States
  • Employees
  • GPCR N/A
  • LMB N/A
  • Industry
  • GPCR
  • LMB Engineering & Construction
  • Sector
  • GPCR
  • LMB Consumer Discretionary
  • Exchange
  • GPCR Nasdaq
  • LMB Nasdaq
  • Market Cap
  • GPCR 1.2B
  • LMB 1.1B
  • IPO Year
  • GPCR 2023
  • LMB 2014
  • Fundamental
  • Price
  • GPCR $33.00
  • LMB $78.42
  • Analyst Decision
  • GPCR Strong Buy
  • LMB Strong Buy
  • Analyst Count
  • GPCR 8
  • LMB 3
  • Target Price
  • GPCR $69.57
  • LMB $130.33
  • AVG Volume (30 Days)
  • GPCR 838.8K
  • LMB 162.8K
  • Earning Date
  • GPCR 11-06-2025
  • LMB 11-04-2025
  • Dividend Yield
  • GPCR N/A
  • LMB N/A
  • EPS Growth
  • GPCR N/A
  • LMB 39.03
  • EPS
  • GPCR N/A
  • LMB 3.03
  • Revenue
  • GPCR N/A
  • LMB $603,582,000.00
  • Revenue This Year
  • GPCR N/A
  • LMB $28.57
  • Revenue Next Year
  • GPCR N/A
  • LMB $14.48
  • P/E Ratio
  • GPCR N/A
  • LMB $25.86
  • Revenue Growth
  • GPCR N/A
  • LMB 16.56
  • 52 Week Low
  • GPCR $13.22
  • LMB $63.02
  • 52 Week High
  • GPCR $40.06
  • LMB $154.05
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 64.72
  • LMB 29.23
  • Support Level
  • GPCR $31.50
  • LMB $77.50
  • Resistance Level
  • GPCR $34.50
  • LMB $101.17
  • Average True Range (ATR)
  • GPCR 1.72
  • LMB 4.91
  • MACD
  • GPCR 0.29
  • LMB -1.35
  • Stochastic Oscillator
  • GPCR 85.30
  • LMB 9.34

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.

Share on Social Networks: